A bivalent conjugate vaccine that protects against serogroups C and Y is available only in combination with tetanus toxoid and Haemophilus influenzae type b vaccine (Hib-MenCY-TT) is approved for children 6 weeks through 18 months of age at increased risk of meningococcal disease; however, Hib-MenCY-TT is no longer available in the US (1).